Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waxman, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waxman, S. G.
NEUROLOGY 1978;28:27-33
© 1978 American Academy of Neurology

Prerequisites for conduction in demyelinated fibers

Stephen G. Waxman, M.D., Ph.D.

Department of Neurology, Harvard Medical School, Beth Israel Hospital, Boston; the Harvard-MIT Division of Health Sciences and Technology; and the Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, MA 02139.

Data are herein reviewed which show that there are structural differences between nodal and internodal membrane in normal myelinated fibers. It appears likely that in most normal myelinated fibers, ionic channel densities in the internodal axon membrane are lower than those at the nodes of Ranvier. Conduction through demyelinated fibers may require structural reorganization, for example, redistribution or production of new channels, in the internodal membrane. Impedance mismatch may also block conduction at sites of demyelination. Reduction in internode distance proximal to the site of demyelination provides one solution to the problem of impedance matching.

Dr. Waxman's address is Department of Neurology, Stanford Medical School, Veterans Administration Hospital, 3801 Miranda Ave. (127), Palo Alto, CA 94304.

This work was supported in part by grants from the U.S. National Multiple Sclerosis Society (RG-1133-A1), the National Institutes of Health (KO4-NS-00010, NS-12307), and the Whitaker Fund.

Accepted for publication May 8, 1978.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by AAN Enterprises, Inc.